Form 4 holding
Vice President, Director, 10%+ Owner
AngioGenex, Inc.
- Security class
- Common Stock
- Shares / value
- 6,043,014
- Estimated value
- Report date
- 06 Jul 2021
- Price
- Ownership
- Direct
Michael M. Strage
Insider Reports History
- Reporting-owner location
- New York, NY
- Latest reporting-owner signature
-
/s/ Michael M. Strage
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Michael M. Strage
Form 4 holding
Vice President, Director, 10%+ Owner
AngioGenex, Inc.
- Security class
- Stock Option
- Shares / value
- 1,333,333
- Estimated value
- Report date
- 02 Sep 2021
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Michael M. Strage
5
AngioGenex, Inc.
- Report period
- 31 Dec 2021
- Transactions
- 3
- Transaction value
- +$4,050,295,000
- Accepted by SEC
- 16 Feb 2022, 15:40
- Role
- Vice President, Director, 10%+ Owner
- Next action
- Open filing details